BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12869917)

  • 1. Treatment outcome of N3 nodal head and neck squamous cell carcinoma.
    Chan SW; Mukesh BN; Sizeland A
    Otolaryngol Head Neck Surg; 2003 Jul; 129(1):55-60. PubMed ID: 12869917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.
    Brizel DM; Prosnitz RG; Hunter S; Fisher SR; Clough RL; Downey MA; Scher RL
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1418-23. PubMed ID: 15050318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
    Argiris A; Stenson KM; Brockstein BE; Mittal BB; Pelzer H; Kies MS; Jayaram P; Portugal L; Wenig BL; Rosen FR; Haraf DJ; Vokes EE
    Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of induction chemotherapy for N3 head and neck squamous cell carcinoma.
    Nishikawa D; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Nakashima T; Hasegawa Y
    Auris Nasus Larynx; 2015 Apr; 42(2):150-5. PubMed ID: 25498333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes following chemoradiotherapy for N3 head and neck squamous cell carcinoma without a planned neck dissection.
    Karakaya E; Yetmen O; Oksuz DC; Dyker KE; Coyle C; Sen M; Prestwich RJ
    Oral Oncol; 2013 Jan; 49(1):55-9. PubMed ID: 22858313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of squamous cell carcinoma of external auditory canal: A tertiary cancer centre experience.
    Gandhi AK; Roy S; Biswas A; Raza MW; Saxena T; Bhasker S; Sharma A; Thakar A; Mohanti BK
    Auris Nasus Larynx; 2016 Feb; 43(1):45-9. PubMed ID: 26165629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].
    Qian W; Zhu G; Ji Q; Guo Y; Wang Y; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):217-22. PubMed ID: 24785284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose preoperative chemoradiation therapy compared with surgery alone with or without postoperative radiotherapy in patients with head and neck carcinoma.
    Mücke T; Konen M; Wagenpfeil S; Kesting MR; Wolff KD; Hölzle F
    Ann Surg Oncol; 2011 Oct; 18(10):2739-47. PubMed ID: 21424882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A planned neck dissection is not necessary in all patients with N2-3 head-and-neck cancer after sequential chemoradiotherapy.
    Soltys SG; Choi CY; Fee WE; Pinto HA; Le QT
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):994-9. PubMed ID: 22137026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
    Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.
    Sun L; Chin RI; Gastman B; Thorstad W; Yom SS; Reddy CA; Nussenbaum B; Wang SJ; Knackstedt T; Vidimos AT; Koyfman SA; Manyam BV
    JAMA Dermatol; 2019 Apr; 155(4):442-447. PubMed ID: 30810715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination of induction chemotherapy with surgery and/or radiotherapy in locally advanced head and neck cancers. A retrospective analysis of a series of 125 patients].
    Ray-Coquard I; Bolla M; Reyt E; Brochon D; Lebeau J; Colonna M; Kolodié H; Vincent F; Chinal-Provencal J
    Bull Cancer; 1997 Sep; 84(9):863-8. PubMed ID: 9435807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic squamous cell carcinoma of the neck from an unknown primary: management options and patterns of relapse.
    Iganej S; Kagan R; Anderson P; Rao A; Tome M; Wang R; Dowlatshahi M; Cosmatos H; Morgan T
    Head Neck; 2002 Mar; 24(3):236-46. PubMed ID: 11891955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Planned neck dissection in the treatment of locally advanced head and neck squamous cell carcinoma].
    Jiang L; Lou JL; Wang KJ; Fang MY; Fu ZF
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):92-96. PubMed ID: 29429177
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer.
    Rengan R; Pfister DG; Lee NY; Kraus DH; Shah JP; Shaha AR; Ben-Porat LS; Zelefsky MJ
    Am J Clin Oncol; 2008 Oct; 31(5):465-9. PubMed ID: 18838883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary.
    Argiris A; Smith SM; Stenson K; Mittal BB; Pelzer HJ; Kies MS; Haraf DJ; Vokes EE
    Ann Oncol; 2003 Aug; 14(8):1306-11. PubMed ID: 12881397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Planned post-chemoradiation neck dissection: significance of radiation dose.
    Stenson KM; Huo D; Blair E; Cohen EE; Argiris A; Haraf DJ; Vokes EE
    Laryngoscope; 2006 Jan; 116(1):33-6. PubMed ID: 16481805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of tumor control and presence of visible necrosis in head and neck cancer patients treated with radiotherapy or radiochemotherapy.
    Kuhnt T; Mueller AC; Pelz T; Haensgen G; Bloching M; Koesling S; Schubert J; Dunst J
    J Cancer Res Clin Oncol; 2005 Nov; 131(11):758-64. PubMed ID: 16088405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative combined chemotherapy and radiation therapy plus radical surgery in advanced head and neck cancer. Five-year results with impressive complete response rates and high survival.
    Slotman GJ; Doolittle CH; Glicksman AS
    Cancer; 1992 Jun; 69(11):2736-43. PubMed ID: 1571903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective trial of chemotherapy-enhanced accelerated radiotherapy for larynx preservation in patients with intermediate-volume hypopharyngeal cancer.
    Kawashima M; Hayashi R; Tahara M; Arahira S; Miyazaki M; Sakuraba M; Zenda S; Ogino T
    Head Neck; 2012 Oct; 34(10):1363-8. PubMed ID: 22076936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.